In today’s trading update, Zamaz (ZAMNZ), founded by Supply’s Dr Frankenstein, Dominic White, provided a trading update under the following caption “Bella Dispensa reports over 30-fold calendar 2022 revenue growth”. The RNS also indicates that “These subsidiary results are being announced as they will shortly be in the public domain in Italy and are price-sensitive.”